CACNA2D1 modulators (Novassay)

N/A

Report date: 2025/06/11 10:54:45
NME

Base Information

Drug NameCACNA2D1 modulators (Novassay)
Drug Alias Namevoltage-dependent calcium channel alpha-2 delta-1 subunit modulators (Novassay)NVA-1503NVA-1505NVA-1509NVA-1511 +[17] 
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel alpha2/delta subunit 1 modulators
TargetsVoltage-gated calcium channel alpha2/delta subunit 1
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovassay SA
China Registration ClassN/A

Develop Information

Active CompaniesNovassay SA
Inactive CompaniesN/A
Active IndicationsNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A